APA |
Erzurumlu, Y., Doğan, H. K., & Çataklı, D. (2023). CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS. Journal of Faculty of Pharmacy of Ankara University, 47(3), 739-751. https://doi.org/10.33483/jfpau.1232868 |
|
AMA |
Erzurumlu Y, Doğan HK, Çataklı D. CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS. J. Fac. Pharm. Ankara. September 2023;47(3):739-751. doi:10.33483/jfpau.1232868 |
|
Chicago |
Erzurumlu, Yalçın, Hatice Kübra Doğan, and Deniz Çataklı. “CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS”. Journal of Faculty of Pharmacy of Ankara University 47, no. 3 (September 2023): 739-51. https://doi.org/10.33483/jfpau.1232868. |
|
EndNote |
Erzurumlu Y, Doğan HK, Çataklı D (September 1, 2023) CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS. Journal of Faculty of Pharmacy of Ankara University 47 3 739–751. |
|
IEEE |
Y. Erzurumlu, H. K. Doğan, and D. Çataklı, “CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS”, J. Fac. Pharm. Ankara, vol. 47, no. 3, pp. 739–751, 2023, doi: 10.33483/jfpau.1232868. |
|
ISNAD |
Erzurumlu, Yalçın et al. “CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS”. Journal of Faculty of Pharmacy of Ankara University 47/3 (September 2023), 739-751. https://doi.org/10.33483/jfpau.1232868. |
|
JAMA |
Erzurumlu Y, Doğan HK, Çataklı D. CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS. J. Fac. Pharm. Ankara. 2023;47:739–751. |
|
MLA |
Erzurumlu, Yalçın et al. “CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS”. Journal of Faculty of Pharmacy of Ankara University, vol. 47, no. 3, 2023, pp. 739-51, doi:10.33483/jfpau.1232868. |
|
Vancouver |
Erzurumlu Y, Doğan HK, Çataklı D. CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS. J. Fac. Pharm. Ankara. 2023;47(3):739-51. |
|